IT HAS been difficult in recent years to make sense of the accounts of UDG Healthcare. Ever since the previous CEO, Liam Fitzgerald, sold off the group’s United Drug Irish and UK distribution business in 2016, shareholders have struggled to get a fix on the group. What has not been made clear, is that things… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!